Cooley LLP advised Pulmonx on the deal. Pulmonx, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, announced its…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
